Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

PCOS is common in women, often treated with lifestyle changes and oral contraceptives.

Low ferritin levels can indicate iron deficiency as a cause of hair loss.

Collagen supplements may improve skin, joints, and recovery, especially with added nutrients.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Dermatologists need to understand African American hair-care practices to better treat their hair and scalp disorders.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Women with PCOS from minority backgrounds have worse mental health and quality of life.

Obese women with PCOS have more cardiovascular risk factors, and waist-to-stature ratio is a better health marker than waist-to-hip ratio.

Obesity and bariatric surgery can cause hair thinning and temporary hair loss due to nutritional deficiencies and stress.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Obesity is common in PCOS patients and early treatment is important for their heart and metabolic health.

Glutamine may protect against alopecia areata, while certain cholesterol and glucose levels may increase risk.

Obesity may weaken the immune system and increase cancer risk.

25% of premenopausal women with Type 1 diabetes have undiagnosed androgen excess disorders.

The online low-carb program was feasible and acceptable for young women with obesity.

Skin changes in obesity can indicate metabolic issues but aren't reliable for assessing risk or monitoring treatment.

DSDs are birth conditions causing unusual sex development, managed with personalized care and sometimes surgery, but still lack a standard treatment approach.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

Improving diet may help manage sleep disorders.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Rapamycin reduces age-related hearing cell loss in mice, but acarbose does not.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

Women with PCOS often experience skin issues like excess hair, acne, and hair loss.

Eating disorders often cause skin issues, which can help in early diagnosis and treatment.